South African pharmaceutical company Aspen Pharmacare announced on Monday, December 29th, the sale of its main Asia-Pacific operations (excluding China) to Australian private equity fund BGH Capital for 2.37 billion Australian dollars, approximately 1.59 billion US dollars. This transaction, which includes markets in Australia, New Zealand, Hong Kong, Taiwan, Malaysia, and the Philippines, is part…...
Trending
- 7th edition of the Financial Afrik Awards: celebrating partnership, vision, and African excellence in Banjul
- Munich 2026: Marco Rubio calls for mobilization of the West against “organized decline”
- AGOA renewed, China zero customs duty: Africa courted
- FANAF Insurance Awards Special 2026: Here are the 6 distinguished winners in Abidjan
- Niger: BCEAO plants its flag in the Tahoua region
- The African Union facing challenges of water, security, and geopolitical issues, gathered in conclave in Addis Ababa for its 39th Summit
- Mining Indaba 2026: Lualaba aims to establish itself as a strategic hub for mining, energy, and logistics in Africa
- Insurance: 8% Increase in Sanlam Morocco’s Profit in 2025
South African Aspen Pharmacare sells key Asia-Pacific operations for $1.6 billion
By Félix NZALÉ
Félix NZALÉ
Félix Nzalé is a Senegalese journalist with a deep passion for cultural issues. He led the "CULTURE" section of SUD QUOTIDIEN (SUD Communication Group) for 10 years. Holder of dual Master’s degrees in Sociology and Philosophy, he also holds a management diploma from the Institut Supérieur de Management (ISM) in Dakar. He has contributed to the development of editorial concepts for several newspapers in Dakar.
Add A Comment
About us
Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, give meaning to statistics….
Contact us: redaction@financialafrik.com